加载中
NASDAQHealthcareMedical - Devices
最新数据
US$0.14
−US$0.0042 · -2.91%
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
常规交易时段
US$0.14
−US$0.0042 · -2.91%
盘中时间采用ET。市场数据可能有所延迟。
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
日内区间
当前US$0.14
52周区间
当前US$0.14
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
67
低估
情绪
59
多空交织
风险
96
极高风险
动量
17
强势下行
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
日内区间
当前US$0.14
52周区间
当前US$0.14
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1744.3万 USD | 1503.1万 USD | 1380.1万 USD | 1602.4万 USD | 1688.5万 USD |
| 销货成本 | 690.1万 USD | 601.2万 USD | 553万 USD | 600.5万 USD | 428.1万 USD |
| 毛利 | 1054.2万 USD | 901.9万 USD | 827.1万 USD | 1001.9万 USD | 1260.4万 USD |
| 销售、一般及管理费用 | 2912.7万 USD | 1960.9万 USD | 2494.6万 USD | 3438.1万 USD | 3134.2万 USD |
| 营业费用 | 3043.6万 USD | 2019万 USD | 2556.7万 USD | 3505万 USD | 3207.5万 USD |
| 利息收入 | — | — | — | 8.9万 USD | 11.7万 USD |
| 利息支出 | — | — | — | — | 1.4万 USD |
| 折旧和摊销 | 130.9万 USD | 58.1万 USD | 62.1万 USD | 66.9万 USD | 73.3万 USD |
| 营业利润 | −1989.4万 USD | −1117.1万 USD | −1729.6万 USD | −2503.1万 USD | −1947.1万 USD |
| 净利润 | −2123万 USD | −1113.6万 USD | −1358.3万 USD | −2384.5万 USD | −2028.8万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$2.13
上涨空间 1421.43%报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
